Program
Tin Fluorides
Also written as “0.454% Stannous Fluoride Dentifrice”, “Stannous fluoride toothpaste” and “Stannous Fluoride”.
Its studies are mostly in Gingivitis · Dentin Sensitivity · Dental Plaque · Diabetes Mellitus, Type 2 · Halitosis, led by 5 companies.
Drug pageTin Fluorides: every studyMany companies study it; this page follows only the 47 they lead. All 44 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Colgate Palmoliveits history only | 182 open or running | phase 4since Feb 6, 2015 | Sep 26, 2008 | Sep 2027phase 4 · NCT07807397 |
| Procter and Gamble | 142 open or running | phase 4since Aug 28, 2025 | Feb 28, 2012 | none ahead |
| GlaxoSmithKlineits history only | 80 open or running | phase 3since May 3, 2012 | May 3, 2012 | none ahead |
| HALEONits history only | 40 open or running | no phasesince Nov 16, 2023 | Nov 16, 2023 | none ahead |
| Church & Dwightits history only | 30 open or running | no phasesince Feb 12, 2026 | Feb 12, 2026 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Procter and Gamble only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Feb 28, 2012First study: no phase study in GingivitisFirst studyNCT01549587 · 746 enrolled · United States
- Sep 4, 2015No phase study in Plaque, AmyloidNCT02543060 · 60 enrolled · United States
- Oct 9, 2015No phase study in Plaque, AmyloidNCT02574221 · 60 enrolled · United States
- Nov 13, 2015No phase study in Oral MalodorNCT02613130 · 60 enrolled · United States
- Jul 11, 2016No phase study in Subgingival PlaqueNCT02841839 · 20 enrolled
- Sep 13, 2017No phase study in Subgingival PlaqueNCT03296657 · 20 enrolled · United States
- Apr 6, 2022No phase study in GingivitisNCT05326373 · 40 enrolled · United States
- Nov 14, 20233 no phase studiesNCT06140784, NCT06140771, NCT06140758
- Oct 23, 2024No phase study in Gingival DiseasesNCT06659471 · 120 enrolled · United States
- Apr 30, 2025Phase 1 study in GingivitisNCT06962956 · 135 enrolled · United States
- Aug 28, 2025Phase 4 study in GingivitisNCT07158112 · 120 enrolled · United States
- Sep 29, 2025Phase 4 study in GingivitisNCT07211061 · 69 enrolled · United States
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 14 Procter and Gamble leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07211061Gingivitis · United States | 4 | Completed | Nov 10, 2011 | 69 |
| NCT07158112Gingivitis · United States | 4 | Active, not recruiting | Dec 7, 2025 | 120 |
| NCT06962956Gingivitis · United States | 1 | Active, not recruiting | Oct 31, 2025 | 135 |
| NCT06659471Gingival Diseases · United States | – | Completed | Jun 6, 2022 | 120 |
| NCT06140784Gingivitis · United States | – | Completed | Dec 10, 2023 | 116 |
| NCT06140771Gingivitis · United States | – | Completed | Feb 6, 2022 | 115 |
| NCT06140758Caries · Australia | – | Completed | Dec 11, 2023 | 12 |
| NCT05326373Gingivitis · United States | – | Completed | Jun 13, 2022 | 40 |
| NCT03296657Subgingival Plaque · United States | – | Completed | Sep 22, 2017 | 20 |
| NCT02841839Subgingival Plaque | – | Completed | Jun 2016 | 20 |
| NCT02613130Oral Malodor · United States | – | Completed | Dec 2015 | 60 |
| NCT02574221Plaque, Amyloid · United States | – | Completed | Oct 2015 | 60 |
| NCT02543060Plaque, Amyloid · United States | – | Completed | Aug 2015 | 60 |
| NCT01549587Gingivitis · United States | – | Completed | Feb 2014 | 746 |
How it is read
Names in the registry
- “0.454% Stannous Fluoride Dentifrice”, 8 entries
- “Stannous fluoride toothpaste”, 7 entries
- “Stannous Fluoride”, 6 entries
- “stannous fluoride toothpaste”, 5 entries
- “Stannous Fluoride Toothpaste (SnF)”, 5 entries
Conditions, from the studies’ own filings
- Gingivitis, 20 studies
- Dentin Sensitivity, 8 studies
- Dental Plaque, 7 studies
- Diabetes Mellitus, Type 2, 1 study
- Halitosis, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.